Anthracyclines: recent developments in their separation and quantitation (Q34510167)

2 August 2017

1 reference

title

Anthracyclines: recent developments in their separation and quantitation (English)

1 reference

2 August 2017

B Gatto

2

0 references

Manlio Palumbo

object named as

M Palumbo

5

0 references

Stefano Moro

object named as

S Moro

3

0 references

author name string

Zagotto G

1

1 reference

2 August 2017

Gatto B

2

1 reference

2 August 2017

Moro S

3

1 reference

2 August 2017

Sissi C

4

1 reference

2 August 2017

Palumbo M

5

1 reference

2 August 2017

G Zagotto

1

0 references

C Sissi

4

0 references

publication date

1 November 2001

1 reference

Journal of Chromatography B: Biomedical Sciences and Applications

2 August 2017

November 2001

0 references

published in

1 reference

2 August 2017

764

1 reference

2 August 2017

1-2

1 reference

2 August 2017

161-171

1 reference

Anthracyclines in the treatment of cancer. An overview

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

Analysis of the effects of daunorubicin and WP631 on transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

Preclinical evaluation of new anthracyclines

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

Role of apoptosis and apoptosis-related genes in cellular response and antitumor efficacy of anthracyclines.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

Catalytic inhibitors of DNA topoisomerase II

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

Solution structure of iron(III)-anthracycline complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

In vivo cellular adriamycin concentrations related to growth inhibition of normal and leukemic human bone marrow cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

Anthracycline analysis by capillary electrophoresis. Application to the analysis of daunorubicine in Kaposi sarcoma tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

Bioanalysis of some anthracyclines in human plasma by capillary electrophoresis with laser-induced fluorescence detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

Determination of doxorubicin hydrochloride by visible spectrophotometry.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

Simultaneous determination of four anthracyclines and three metabolites in human serum by liquid chromatography-electrospray mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

Determination of doxorubicin and metabolites in murine specimens by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

Simultaneous determination of epirubicin, doxorubicin and their principal metabolites in human plasma by high-performance liquid chromatography and electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

Determination of doxorubicin and doxorubicinol in plasma of cancer patients by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

High-performance liquid chromatographic validated assay of doxorubicin in rat plasma and tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

Simultaneous quantitation of plasma doxorubicin and prochlorperazine content by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

Gamma scintigraphy of the biodistribution of 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in mice with transplanted melanoma and mammary carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

HPLC methods for the determination of bound and free doxorubicin, and of bound and free galactosamine, in methacrylamide polymer-drug conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

A sensitive procedure for the quantitation of free and N-(2-hydroxypropyl) methacrylamide polymer-bound doxorubicin (PK1) and some of its metabolites, 13-dihydrodoxorubicin, 13-dihydrodoxorubicinone and doxorubicinone, in human plasma and urine by r

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

Simultaneous high-performance liquid chromatographic determination of a glucuronyl prodrug of doxorubicin, doxorubicin and its metabolites in human lung tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

Simultaneous determination of cytotoxic (adriamycin, vincristine) and modulator of resistance (verapamil, S 9788) drugs in human cells by high-performance liquid chromatography and ultraviolet detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

Determination of idarubicin and idarubicinol in rat plasma using reversed-phase high-performance liquid chromatography and fluorescence detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

Determination of idarubicin and idarubicinol in plasma by capillary electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

Determination of plasma concentrations of epirubicin and its metabolites by high-performance liquid chromatography during a 96-h infusion in cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

Coupled-column liquid chromatographic analysis of epirubicin and metabolites in biological material and its application to optimization of liver cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

Evaluation and routine application of the novel restricted-access precolumn packing material Alkyl-Diol Silica: coupled-column high-performance liquid chromatographic analysis of the photoreactive drug 8-methoxypsoralen in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

Stability and compatibility studies of zorubicin in intravenous fluids and PVC infusion bags

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900346-2

7 January 2021

10.1016/S0378-4347(01)00346-2

Identifiers

DOI

0 references

1 reference